Evaluating the health and economic impact of a risk group based strategy for seasonal influenza in low and middle income countries (LMICs)

PI: Mark Jit
Funding: WHO

The World Health Organization’s expert committee on vaccination (SAGE) has recommended introducing seasonal influenza vaccination for pregnant women, then for health care workers, people in clinical risk groups, the elderly and children. However, economic evidence to support such introduction decisions is scarce in low and middle income countries. This project is a package of economic studies to inform decision making, providing economic evidence about both the direct and indirect impact and cost-effectiveness of targeting different groups in different countries of the world. It is a collaboration between a consortium led by LSHTM, and also consisting of Public Health England, Imperial College London, the Centre for Global Health Research in Toronto and the Health Intervention and Technology Assessment Programme in Thailand.